Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Investment Research Dashboard
About Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) stock analysis
Get live BJTRF stock price $0.64, comprehensive Beijing Tong Ren Tang Chinese Medicine Company Limited stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BJTRF stock data and investment insights.
Loading chart data...
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) Overview
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Pharmaceuticals industry . As of the latest trading session, BJTRF trades at $0.64 with a market capitalization of 535.91M . Over the past 52 weeks, BJTRF has traded between $0.64 and $0.65 , with the current price positioned at approximately 0...
Key Takeaways
- Operates in the Healthcare sector (Medical - Pharmaceuticals)
- Market cap: 535.91M
- Current price: $0.64
- 52-week range: $0.64 - $0.65
- P/E ratio: 7.10
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) is an entity primarily engaged in the manufacturing, retailing, and wholesale distribution of traditional Chinese medicine and various healthcare products, catering to both bulk purchaser...
Company Information
- CEO
- Wang Chi
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Employees
- 780
Contact Information
- Website
- https://cm.tongrentang.com
- Address
- Office Tower
- Country
- HK
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 7.1)
✓ Lower volatility stock (Beta: 0.34) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Beijing Tong Ren Tang Chinese Medicine Company Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Beijing Tong Ren Tang Chinese Medicine Company Limited
- ⚠Investors should consider how Beijing Tong Ren Tang Chinese Medicine Company Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
535.91M
P/E Ratio (TTM)
7.10
Beta
0.34
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BJTRF with peer companies:
- Price
- $0.15+0.00% (1D)
- Market cap
- 756.30M
- Price
- $21.28-5.37% (1D)
- Market cap
- 626.73M
- Price
- $31.50+0.00% (1D)
- Market cap
- 546.91M
- Price
- $13.49-3.64% (1D)
- Market cap
- 321.76M
- Price
- $2.45-3.16% (1D)
- Market cap
- 1.47B
- Price
- $0.00+0.00% (1D)
- Market cap
- 97.18K
- Price
- $0.09+0.00% (1D)
- Market cap
- 14.67M
- Price
- $38.43+0.00% (1D)
- Market cap
- 897.16M
- Price
- $0.00+0.00% (1D)
- Market cap
- 16.55K
- Price
- $0.00+0.00% (1D)
- Market cap
- 1.71K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.